ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

LMNX Luminex Corporation

36.99
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Luminex Corporation NASDAQ:LMNX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 36.99 36.94 36.98 0 01:00:00

Luminex Corporation to Present at Pacific Growth Equities Life Sciences Growth Conference

06/06/2006 4:00pm

PR Newswire (US)


Luminex (NASDAQ:LMNX)
Historical Stock Chart


From Aug 2019 to Aug 2024

Click Here for more Luminex Charts.
AUSTIN, Texas, June 6 /PRNewswire-FirstCall/ -- Luminex Corporation (NASDAQ:LMNX) today announced that management will present at the Pacific Growth Equities Life Sciences Growth Conference 2006 to be held June 12-14, 2006, in San Francisco, California. The investor presentation by Patrick J. Balthrop, president and chief executive officer, and Harriss T. Currie, chief financial officer, will begin at 9:00 a.m. Pacific time on Tuesday, June 13, 2006. The presentation will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com/. Simply log on to the web at the address above, go to the Company section and access the Investor Relations link. Please go to the website at least 15 minutes prior to the event to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the presentation will be archived for one year on the website using the 'replay' link. Luminex Corporation develops, manufactures and markets proprietary biological testing technologies with applications throughout the life sciences industry. The Company's xMAP(R) system is an open-architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics research markets. The Company's xMAP technology is sold worldwide and is in use in leading research laboratories as well as major pharmaceutical, diagnostic and biotechnology companies. Further information on Luminex Corporation or xMAP can be obtained on the Internet at http://www.luminexcorp.com/. Contact: Harriss T. Currie Vice President, Finance and Chief Financial Officer 512-219-8020 DATASOURCE: Luminex Corporation CONTACT: Harriss T. Currie, Vice President of Finance and Chief Financial Officer of Luminex Corporation, +1-512-219-8020 or

Copyright

1 Year Luminex Chart

1 Year Luminex Chart

1 Month Luminex Chart

1 Month Luminex Chart